-Receptor-mediated inhibition of amiloride-sensitive sodium absorption was observed in primary and immortalized murine renal collecting duct cell (mCT12) monolayers. The addition of epidermal growth factor (EGF) to the basolateral bathing solution of polarized monolayers reduced amiloride-sensitive short-circuit current (I sc) by 15-25%, whereas the addition of ATP to the apical bathing solution decreased Isc by 40 -60%. Direct activation of PKC with phorbol 12-myristate 13-acetate (PMA) and mobilization of intracellular calcium with 2,5-di-tert-butyl-hydroquinone (DBHQ) reduced amiloride-sensitive I sc in mCT12 monolayers by 46 Ϯ 4% (n ϭ 8) and 22 Ϯ 2% (n ϭ 8), respectively. Exposure of mCT12 cells to EGF, ATP, PMA, and DBHQ caused an increase in phosphorylation of p42/p44 (extracellular signal-regulated kinase; ERK1/2). Pretreatment of mCT12 monolayers with an ERK kinase inhibitor (PD-98059; 30 M) prevented phosphorylation of p42/p44 and significantly reduced EGF, ATP, and PMA-induced inhibition of amiloride-sensitive I sc. In contrast, pretreatment of monolayers with a PKC inhibitor (bisindolylmaleimide I; GF109203x; 1 M) almost completely blocked the PMA-induced decrease in I sc, but did not alter the EGF-or ATP-induced inhibition of Isc. The DBHQ-mediated decrease in I sc was due to inhibition of basolateral Na ϩ -K ϩ -ATPase, but EGF-, ATP-, and PMA-induced inhibition was most likely due to reduced apical sodium entry (epithelial Na ϩ channel activity). The results of these studies demonstrate that acute inhibition of amiloride-sensitive sodium transport by extracelluar ATP and EGF involves ERK1/2 activation and suggests a role for MAP kinase signaling as a negative regulator of electrogenic sodium absorption in epithelia.
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mitogen-activated protein kinase; epithelial ion transport; epithelial sodium channel AMILORIDE-SENSITIVE Na ϩ transport, mediated by the epithelial Na ϩ channel (ENaC), is an important pathway for Na ϩ absorption by the colon and for Na ϩ retention by the distal nephron (16) . A similar mechanism for Na ϩ transport is in the salivary duct, urinary bladder, sweat duct, and airway epithelium, where the process is responsible for the clearance of fetal lung liquid at birth (9, 28) and for control of the composition and/or depth of airway surface liquid in the postnatal lung (4) . Defective regulation of ENaC and resultant Na ϩ hyperabsorption by the airway surface epithelium is thought to be an important component of the pathophysiology of cystic fibrosis (5) . ENaC loss-of-function mutations (e.g., pseudohypoaldosteronism type I) are known to cause hyponatremia, hyperkalemia, and salt wasting, whereas gain-of-function mutations (e.g., salt-sensitive hypertension, Liddle's syndrome) lead to an increase in ENaC activity and excess Na ϩ reabsorption (20, 31) .
Corticosteroids, insulin, and vasopressin cause acute and/or chronic stimulation of sodium transport in epithelial cells (45) by several mechanisms, including alterations in ENaC open probability (23) , increased synthesis of channel subunits (2) , enhanced trafficking of the channel to the plasma membrane (1), and decreased retrieval of channels from the apical membrane (11, 35) . Several receptor agonists cause acute and/or chronic downregulation of Na ϩ absorption, including epidermal growth factor (EGF) (10, 32, 43, 46) , acetylcholine and PGE 2 (6, 15, 17, 46) , and extracellular ATP (26) . Several intracellular signaling pathways (i.e., PKC, calcium, Src kinase, ERK1/2) have been implicated (17, 18, 21, 24, 43, 47) ; however, the precise molecular mechanisms responsible for inhibition of ENaC function have not been fully elucidated.
ENaC belongs to the degenerin/ENaC gene superfamily, and functional channels are thought to be composed of some combination of three homologous subunits: ␣-, ␤-, and ␥-ENaC (7) . Each subunit has the predicted membrane topology of two hydrophobic membrane-spanning regions, a highly conserved large extracellular cysteine-rich loop, and intracellular NH 2 and COOH termini. The COOH termini of all three subunits of ENaC contain well-conserved PY (PPPxY) motifs that represent potential binding sites for Nedd4 ubiquitin ligases, and disruption/deletion of the PY motif in ␤-or ␥-ENaC leads to enhanced ENaC function (19, 34) . Garty and coworkers (8, 33) recently showed that ERK2-mediated phosphorylation of Thr613 (␤-ENaC) and Thr623 (␥-ENaC), residues located near the PY motifs, facilitates Nedd4 binding and mutation of these residues and also increases amiloride-sensitive current in Xenopus oocytes expressing these channels.
EGF and extracellular ATP inhibit amiloride-sensitive sodium absorption in several epithelia, including renal collecting duct (26, 43) , airway (13) , colon, and endometrium (10) . There are conflicting results with regard to whether elevation of intracellular calcium (12, 13, 21, 43) , activation of PKC (24) , or neither (26, 40) is required for the inhibitory response. Whereas activation of ERK1/2 by EGF is common to many cell types, there is no direct demonstration that ERK1/2 plays a role in acute receptor-mediated downregulation of sodium transport in epithelia. Because both EGF and extracellular ATP are known to induce phosphorylation and activation of ERK1/2 (32, 42) , the present study was undertaken to determine the role of the MAP kinase cascade as a negative regulator of sodium transport. The results of these studies demonstrate that phosphorylation and activation of ERK1/2 is an important step in ATP-and EGFinduced inhibition of amiloride-sensitive sodium transport.
METHODS
Cell isolation and culture. Experiments were carried out with primary cultures of mouse renal epithelial cells and an immortalized mouse collecting duct principal cell line (mCT12). The collecting duct cell line used in these studies was generated as described previously (32, 38, 39) . To prepare primary cultures of mouse renal epithelial cells, the kidneys were removed from transgenic HoxB7/EGFP ϩ/Ϯ mice (36) (ureteric bud and collecting duct specific expression of enhanced green fluorescent protein) under sterile conditions from CO 2-euthanized animals. The renal capsule was removed and the kidneys were minced with a razor blade, rinsed with sterile HEPESbuffered Ringer solution, and suspended in 10 ml of collecting tubule (CT) media that contained collagenase (0.625 mg/ml, Type IV; Worthington Biochemical). The tissue was digested for 10 -30 min at 37°C in a shaking water bath. The cellular material was collected by centrifugation, resuspended in CT media, plated onto plastic tissue culture dishes, and placed in a humidified tissue culture incubator (37°C and 5% CO 2). The media were changed 24 h later and every 48 h thereafter. Primary cultures were expanded for 5-7 days, seeded onto collagen-coated permeable supports, and studied 5-10 days later. Some experiments with primary mouse renal epithelial cells were done on an enriched preparation of collecting duct principal cells (Ͼ95% purity) obtained by fluorescence-activated cell sorting for EGFP (collecting duct) cells (44) . The cells isolated by fluorescenceactivated cell sorting were seeded onto collagen-coated permeable supports and studied 5-10 days later. The studies described herein were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee of Case Western Reserve University School of Medicine.
CT media were composed of the following: a 1:1 mix of Dulbecco's modified Eagle's medium and Ham's F-12 medium (Life Technologies) supplemented with 1.3 g/l sodium selenite, 1.3 g/l 3,3Ј,5-triiodo-L-thyronine, 5 mg/l insulin, 5 g/l transferrin, 25 g/l prostaglandin E1, 2.5 mM glutamine, 50 nM dexamethasone, 50 mg/l streptomycin, and 30 mg/l penicillin G. Interferon-␥ (10,000 U/l) was added to the CT media for mCT12 cells.
Transepithelial electrical measurements. Cells were seeded (2-5 ϫ 10 5 cells/filter) onto collagen-coated, permeable supports (modified 12 mm Millicell-CM filters; Millipore) as described previously (39) . Confluent cell monolayers were mounted vertically in a thermostatically controlled Ussing chamber equipped with gas inlets and separate reservoirs for the perfusion of apical and basolateral compartments. Both sides of the cell monolayer were bathed with equal volumes of Krebs-Ringer bicarbonate solution containing (in mM): 115 NaCl, 25 NaHCO 3, 5 KCl, 2.5 Na2HPO, 1.8 CaCl2, 2 MgSO4, and 10 glucose. Some experiments were done with cell monolayers bathed by CT media. The solutions were circulated through the water-jacketed glass reservoir by gas lifts (95% O 2-5% CO2) to maintain solution temperature at 37°C and pH at 7.4. Transepithelial voltage difference (VT) was measured between two Ringer-agar bridges, and calomel halfcells connected the bridges to a high impedance voltmeter. Current from an external direct current source was passed by silver-silver chloride electrodes and Ringer-agar bridges to clamp the spontaneous V T to 0 mV. The current required [short-circuit current (Isc)] was corrected for solution and filter series resistance and recorded. Monolayers were maintained under short-circuit conditions except for brief 3-to 5-s intervals when the current necessary to clamp the voltage to a nonzero value (2-10 mV) was measured to calculate transepithelial resistance.
Western blots. Cell lysates were prepared from confluent culture filters (24 mm Transwell, Clear tissue culture treated; Corning Costar) in lysis buffer containing 50 mM Tris ⅐ HCl (pH 7.5), 1% Triton X-100, 3 mM EDTA, and 1 mM EGTA. Protein concentrations were measured by bicinchoninic acid protein assay (Pierce). Western blot analysis for total and phosphorylated ERK1/2 (p42/p44) was performed as described previously (32) .
Statistical analysis. All results are expressed as means Ϯ SE. Statistical significance was evaluated by either paired or unpaired Student's t-test. P Ͻ 0.05 was considered significant.
RESULTS
EGF and extracellular ATP inhibit amiloride-sensitive sodium absorption. Primary cultures of renal collecting duct principal cells form polarized epithelial monolayers and exhibit I sc . As illustrated in Fig. 1 , the I sc is sensitive to amiloride (Ͼ95% inhibition), an ENaC blocker, and to EGF and extracellular ATP. Addition of EGF (20 ng/ml) to the basolateral bathing solution elicits, after a ϳ5-min delay, a monotonic decrease in I sc (ϳ25%), and the remaining current is inhibited by subsequent addition of amiloride (Fig. 1A) . Pretreatment of the monolayer with amiloride leads to almost complete inhibition of I sc and subsequent addition of EGF does not elicit a change in I sc (Fig. 1B ). The addition of ATP (100 M) to the apical bathing solution causes a transient increase in I sc (anion secretion), followed by a decline in I sc (Fig. 1C ) to a value below the initial current. Pretreatment of the monolayer with amiloride does not block the transient stimulation of I sc by ATP, but does prevent a drop in current below the value recorded immediately before the addition of ATP (Fig. 1D) . The inhibitory effects of EGF and ATP on amiloride-sensitive I sc in monolayers of primary mouse collecting duct principal cells and immortalized mCT12 are summarized in Fig. 2 . Additional experiments were done with mCT12 to identify the signaling pathways responsible for inhibition of amiloridesensitive sodium absorption by EGF and ATP.
ERK1/2 activation contributes to acute EGF-and ATPinduced inhibition of amiloride-sensitive sodium absorption.
Previous studies have shown that acute exposure of isolated, perfused collecting ducts to either EGF or extracellular ATP causes inhibition of sodium absorption; however, the mechanism of inhibition is unknown. Furthermore, chronic exposure (12-48 h) of immortalized collecting duct principal cells to EGF reduces amiloride-sensitive I sc via an ERK1/2-dependent pathway. To determine whether activation of MAP kinase signaling is responsible for the acute effects of EGF on sodium absorption, the epithelial monolayers were treated with an inhibitor of ERK kinase (PD-98059) before exposure to EGF. Typical I sc traces (Fig. 3 , A-D) and summary data ( Fig. 3E ) reveal that addition of PD-98059 (30 M; apical and basolateral) to mCT12 epithelial monolayers had no significant effect on amiloride-sensitive I sc , yet completely prevented the EGFinduced inhibition of I sc . Similar results were obtained with another MEK inhibitor (U0126; 10 M; data not shown).
Activation of the ERK signaling cascade by EGF elicits rapid phosphorylation of p42/p44 MAPK (ERK1/2). As illustrated in Fig. 4 , exposure of mCT12 cells to EGF or extracellular ATP resulted in an increase in phospho-p42/p44 MAPK compared with unstimulated cells. Because extracellular nucleotide triphosphates, acting at purinergic receptors, are thought to signal through PKC and/or elevated calcium, the effects of PKC activation and calcium mobilization on ERK signaling were investigated. Exposure of mCT12 cells to phor-bol 12-myristate 13-acetate (PMA; 0.5 M; apical) to activate PKC or elevation of intracellular calcium by exposure to an endoplasmic reticulum Ca-ATPase inhibitor [2,5-di-tert-butylhydroquinone (DBHQ), 25 M; apical] led to enhanced phosphorylation of p42/p44 (Fig. 4) . In all cases, the increased phosphorylation of p42/p44 was almost completely prevented by pretreatment with PD-98059.
The inhibitory effects of EGF, ATP, PMA, and DBHQ on amiloride-sensitive I sc and the ability of an ERK kinase inhibitor (PD-98058) and a PKC inhibitor (BIM) to modulate the responses were evaluated in a series of experiments similar to those depicted in Fig. 3 , A-D, and the results are summarized in Figs. 5 and 6. The inhibitory effects of EGF, ATP, and PMA on amiloride-sensitive I sc were completely (EGF) or partially (ATP and PMA) blocked by pretreatment of the monolayers with the ERK kinase inhibitor (PD-98059). In contrast, the DBHQ-induced inhibition of amiloride-sensitive I sc was completely insensitive to the ERK kinase inhibitor (Fig. 5) . Similar experiments were conducted using a PKC inhibitor [bisindolylmaleimide I (BIM) GF109203x; 1 M] to evaluate the role of PKC as a mediator of EGF-and ATP-induced downregulation of sodium absorption. As shown in Fig. 6 , treatment of the monolayers with BIM almost completely prevented the PMAinduced inhibition of I sc but had no effect on EGF, ATP, or DBHQ-induced inhibition. Neither PD-98059 nor BIM caused significant changes in I sc compared with vehicle controls (Figs. 5 and 6). The addition of ATP to the apical bathing solution elicited a 40 -50% decrease in amiloride-sensitive I sc that was prevented in part by PD-98059 but not by BIM (Fig. 6) .
Basolateral membrane Na ϩ -K ϩ -ATPase pump current is not inhibited by EGF, ATP, and PMA. Electrogenic transepithelial sodium absorption is often mediated by amiloride-sensitive Na ϩ channels (ENaC) in the apical plasma membrane and K channels and ouabain-sensitive Na ϩ -K ϩ -ATPase in the basolateral plasma membrane. The acute inhibitory effects of EGF, ATP, PMA, and DBHQ on I sc could be due to an effect on apical and/or basolateral transport proteins. To electrically isolate the basolateral membrane and to evaluate the effects of EGF, ATP, PMA, and DBHQ on ouabain-sensitive pump activity, the apical plasma membrane of mCT12 monolayers was rendered permeable to monovalent ions by exposure to amphotericin B. As illustrated in Fig. 7A , the addition of amiloride to the apical bathing solution reduced I sc to near zero, and subsequent addition of amphotericin to the apical bathing solution caused a rapid increase in I sc . Approximately 30 min later, ouabain was added to the basolateral bathing solution and the I sc was rapidly reduced toward zero. If the epithelial monolayer was treated with amphotericin before exposure to amiloride, the inhibitory effect of amiloride on sodium absorption was prevented, but subsequent treatment with ouabain again significantly reduced I sc . The effects of EGF, ATP, PMA, and DBHQ on pump current were measured after the addition of amiloride and then amphotericin B to the apical bathing solution to generate a sustained current. EGF, ATP, and PMA did not produce a significant change in current (Fig. 7, B-F and I) , whereas DBHQ induced a rapid decrease in current either with or without prior treatment with amphotericin B (Fig. 7, G-I) . The time course and the magnitude of the inhibition of pump current by DBHQ closely paralleled the inhibition of I sc in the intact monolayer, suggesting that the primary effect of DBHQ-induced calcium mobilization on sodium absorption is via inhibition of Na ϩ -K ϩ -ATPase, whereas the inhibitory effects of EGF, ATP, and PMA are most likely due to inhibition of apical ENaC activity.
EGF-induced inhibition is reversible. In a final set of experiments, the reversibility of the EGF-induced ERK1/2 phosphorylation and inhibition of amiloride-sensitive sodium absorption were tested. As illustrated in Fig. 8E , EGF-induced phorphorylation of ERK1/2 was rapidly reversed by addition of an ERK kinase inhibitor (U0126) to monolayers. ERK1/2 phosphorylation level was essentially constant between 15 and 30 min after the addition of EGF to the basolateral bathing solution. The addition of U0126 to the monolayers during the plateau phase of EGF-induced ERK1/2 phosphorylation led to a dose-dependent reversal of ERK1/2 phosphorylation (Fig.  8E) . Similarly, the decrease in I sc elicited by EGF was partially reversed by the addition of U0126, whereas addition of the ERK kinase inhibitor produced only a small decrease in I sc (ϳ3-4%) independent of the presence or absence of EGF treatment. Individual traces are shown in Fig. 8 , A-C, and summary data are depicted in Fig. 8D .
DISCUSSION
Previous studies demonstrated acute inhibition of amiloridesensitive sodium absorption and/or ENaC activity by a variety of receptor agonists, including EGF (10, 43), endothelin (15, 17) , and extracellular nucleotide triphosphates (21, 24, 26) . PKC (24) , calcium (22, 43) , arachidonic acid (47) , and Src kinase (17) were implicated as intracellular signaling intermediates; however, there are conflicting data, and the precise mechanisms of inhibition have not been elucidated. Activation of MAP kinase signaling (ERK1/2) is a common event in renal cells exposed to EGF, acetylcholine, endothelin, and extracellular ATP as well as other receptor agonists (41). Garty and coworkers (8, 33) showed recently that ERK2 can phosphorylate well-conserved threonines in COOH terminal peptides from the ␤-and ␥-subunits of ENaC and suggested that MAP kinases may play a role in regulating ENaC. We showed previously (32) that prolonged exposure of renal collecting duct cell lines to EGF or PMA leads to activation of MAP kinase signaling and subsequent downregulation of ENaCmediated sodium absorption (50 -60% decrease). Phosphorylation of ERK1/2 (p42/44) and inhibition of sodium absorption were prevented by pretreatment with an inhibitor of ERK kinase, and a transcriptional mechanism was proposed based on the finding that EGF caused a 70 -85% decrease in the steady-state levels of the ␣-, ␤-, and ␥-ENaC subunit mRNAs. The results of the experiments presented herein reveal an additional, nontranscriptional, ERK1/2-dependent mechanism for rapid downregulation of sodium absorption.
EGF-mediated inhibition of I sc . Studies of in vitro perfused cortical collecting duct (43, 46) and primary cultures of endometrial epithelial cells (10) found that EGF caused rapid inhibition of sodium transport. On the basis of changes in membrane potential and direct measurements of apical membrane sodium conductance in permeabilized monolayers, the primary site of action of EGF-induced inhibition of sodium absorption was localized to the apical sodium channel (10, 46) . We were able to reproduce the effects of EGF on sodium absorption in mouse collecting duct cells and in immortalized mouse collecting duct principal cells. Fig. 6 . Effects of a PKC inhibitor on EGF-, ATP-, PMA-, and DBHQ-induced inhibition of amiloride-sensitive Isc. The experiments were conducted as illustrated in Fig. 3 . Sets of 4 mCT12 monolayers were exposed to either vehicle, kinase inhibitor (BIM, 1 M apical and basolateral), agonist (EGF, ATP, PMA, DBHQ), or kinase inhibitor, followed by agonist. The amiloride-sensitive currents for each condition are normalized to the time-control monolayer (i.e., treated with vehicle) and expressed as INa-exp/INa-con. The mean initial Isc for the control monolayers was 29.9 Ϯ 0.7 A/cm 2 (n ϭ 27), and the mean starting value was not different in all subgroups. *P Ͻ 0.05, significant agonist-induced decrease in amiloride-sensitive Isc; ϩP Ͻ 0.05, significant effect of PD-98059 pretreatment on agonist-induced inhibition of Isc. Fig. 3 . Sets of 4 mCT12 monolayers were exposed to either vehicle, kinase inhibitor (PD-98059, 30 M apical and basolateral), agonist (EGF, ATP, PMA, DBHQ), or kinase inhibitor, followed by agonist. The amiloride-sensitive currents for each condition are normalized to the timecontrol monolayer (i.e., treated with vehicle) and expressed as amiloridesensitive current of treated monolayer divided by amiloride-sensitive current in control monolayer (INa-exp/INa-con). The mean initial Isc for the control monolayers was 31.4 Ϯ 0.8 A/cm 2 (n ϭ 24), and the mean starting value was not different in all subgroups. *P Ͻ 0.05, significant agonist-induced decrease in amiloride-sensitive Isc; ϩP Ͻ 0.05, significant effect of PD-98059 pretreatment on agonist-induced inhibition of Isc.
The studies cited above concluded that elevation of intracellular calcium directly inhibited sodium channels and/or activated PKC to cause EGF-induced inhibition of sodium absorption. Whereas permissive changes in calcium or activation of specific PKC isoforms cannot be ruled out, our results are not consistent with such a mechanism of action, because 1) the inhibitory effect of EGF on I sc was completely blocked by pretreatment with inhibitors of MEK (PD-98059 and U0126), 2) inhibition of I sc in response to calcium mobilization (DBHQ) was insensitive to MEK inhibition and could be explained by a reduction in basolateral Na ϩ -K ϩ -ATPase function, and 3) EGF-induced inhibition of I sc was insensitive to a general PKC inhibitor (BIM). Fig. 7 . Effect of agonists on ouabain-sensitive Na ϩ -K ϩ -ATPase-mediated current in permeabilized mCT12 monolayers. Monolayers were mounted in Ussing chambers, and amiloride (Amil) was added to the apical bathing solution to inhibit spontaneous Na ϩ absorption. The pore-forming antibiotic amphotericin B (AmB) was added to the apical bathing solution at a final concentration of 30 M to increase the permeability of the apical plasma membrane to monovalent ions. After Isc stabilized (10 -15 min), EGF (20 ng/ml; basolateral), ATP (100 M, apical), PMA (500 nM, apical), or DBHQ (25 M, apical) was added and the effect on Isc (pump current) was monitored for 30 min. At the end of each experiment, ouabain (Ob; 10 mM) was added to the basolateral bathing solution to confirm that the Isc was mediated by the sodium pump. A-H: representative traces showing the effects of various compounds added at the indicated times. I: summary of the effects of EGF, ATP, PMA, and DBHQ on pump currents. Vehicle-treated time controls were run in parallel and were used to express the data as a percentage of control current (i.e., monolayers treated with amphotericin B but not with EGF, ATP, PMA, or DBHQ). Values are means Ϯ SE; n ϭ 6 -8 monolayers for each condition. *P Ͻ 0.05, significant agonist-induced decrease in pump current compared with untreated controls (unpaired ttest).
ATP-mediated inhibition of I sc . Extracellular nucleotide triphosphates are known to inhibit amiloride-sensitive sodium absorption in airway epithelium (13, 21) , endometrial cells (30) , and distal renal tubules (24, 26, 40) . A variety of studies have been conducted in freshly isolated tissues, primary cultures, and cell lines from multiple species, but there is not a consensus as to the mechanism(s) responsible for inhibition of sodium transport. Most of the results support a role for calcium mobilization (13, 21) , but not PKC activation, despite evidence that direct activation of PKC with phorbol esters can lead to inhibition of amiloride-sensitive sodium absorption in airways (18, 25) . O'Grady and coworkers (30) recently reported that extracellular UTP elicited a transient stimulation of Cl secretion, followed by a sustained inhibition of amiloride-sensitive sodium absorption in cultured porcine endometrial epithelial cells. They found that the inhibition of sodium transport was due to a PKC-dependent decrease in apical sodium conductance, mediated by both calcium-dependent and calcium-independent PKC isoforms. Studies of ATP-and UTP-mediated inhibition of sodium transport in renal connecting tubules and collecting duct cells have also yielded mixed results. Koster et al. (24) concluded that extracellular ATP-mediated inhibition of sodium absorption in primary cultures of rabbit cortical collecting duct (CCD) and connecting tubule was due to PKC activation; however, Leipziger and coworkers (26, 40) found no evidence of a role for calcium or PKC activation in ATP-induced inhibition of sodium transport in immortalized murine collecting duct principal cells (M1 cells) or in perfused mouse CCD. In contrast, the present studies of immortalized collecting duct principal cells (mCT12) clearly showed that elevation of intracellular calcium or activation of PKC (Figs. 5 and 6) can elicit inhibition of amiloride-sensitive sodium absorption. Furthermore, PKC-mediated inhibition is almost completely prevented by pretreatment with a PKC inhibitor (Fig. 6 ). The importance of these two pathways in ATPinduced inhibition of apical sodium entry is less certain because the PKC inhibitor did not alter the ATP-induced decrease in I sc (Fig. 6 ) and the effect of calcium mobilization on sodium absorption can be explained by inhibition of basolateral Na (Fig. 7) . Recent studies by Eaton and coworkers (48) demonstrated that phosphatidylinositol 4,5-bisphosphate stimulates ENaC, and they speculated that local depletion of phosphatidylinositol 4,5-bisphosphate in response to purinergic stimulation of PLC could underlie the ATP-induced inhibition of ENaC activity. Our results do not address the mechanism of ATP-induced inhibition of sodium absorption, but they do support a role for the MAP kinase signaling cascade because 1) exposure to extracellular ATP elicited rapid phosphorylation of ERK1/2 (p42/44), 2) ATP-induced phosphorylation of ERK1/2 was prevented by an inhibitor of ERK kinase, and 3) inhibition of ERK1/2 phosphorylation partially blocked (ϳ50%) the inhibitory effects of ATP on sodium absorption.
Mechanism of ERK1/2-mediated inhibition of amiloridesensitive sodium absorption. Several recent studies bear directly on the mechanisms of MAP kinase-mediated regulation of ENaC. Garty and coworkers (33) showed that ERK2 could phosphorylate COOH terminal peptides from the ␤-and ␥-subunits of ENaC. They suggested that ERK2-mediated phosphorylation of ␤-Thr613 and ␥-Thr623, amino acids adjacent to PY motifs implicated in channel endocytosis, could promote ENaC-Nedd4 interaction and facilitate channel retrieval. Lysine residues in the ␣-and ␥-subunits of heterologously expressed ENaC can be ubiquitinated and mutations in the critical lysines increase ENaC activity, presumably by decreasing channel endocytosis (33, 37) . A role for MAP kinase in PKC-mediated degradation of ENaC in A6 cells was recently proposed (3) . The authors used immunodetection of ENaC subunits to argue that PKC caused enhanced degradation of ␤-and ␥-, but not ␣-ENaC. The evidence for involvement of ERK1/2 activation in the process was based on partial inhibition of PKC induced loss of ␤-and ␥-ENaC by MEK inhibitors. Unfortunately, the earliest time point at which inhibitors of MAP kinase signaling were tested was 6 h, so it is difficult to unequivocally assign a role for ERK1/2 in the early decrease in sodium transport after PKC activation (i.e., PKC causes ϳ90% inhibition of I sc within 60 min in A6 cells). They also showed that in the presence of cycloheximide, to block channel synthesis, proteosome inhibitors prevented the PMA-induced loss of ␥-ENaC, but failed to prevent the PMA-induced decrease in I sc . Previous studies of PKC-induced inhibition of ENaC function have suggested that PKC rapidly decreases open probability with a slower decrease in the number of active channels; however, the role of ERK1/2 activation was not evaluated (14) . Nicod et al. (27) reported that the vasopressininduced transcript VIT32, when coexpressed with ENaC in oocytes, caused MAP kinase activation and ENaC downregulation. Despite a 50% decrease in ENaC current, there was no detectable change in surface expression of ENaC, suggesting a decrease in channel open probability rather than endocytosis. The studies described in this article do not directly address the mechanisms by which ERK1/2 activation leads to a decrease in amiloride-sensitive sodium absorption, but the rapid reversibility of the EGF-induced decrease in I sc is relevant. Reversal of EGF-induced inhibition of sodium absorption by addition of a MEK inhibitor implies that 1) ERK1/2 does not exert tonic inhibition on sodium absorption under the conditions of our experiments, 2) sustained activation of ERK1/2 is required for acute inhibition of sodium absorption by EGF, 3) ERK1/2 is rapidly dephosphorylated, and 4) ERK1/2-dependent changes in ENaC activity are rapidly reversible. These observations suggest that the early effects of ERK1/2 activation may not involve channel degradation but may be due to reversible endocytosis (recycling endosomes) or channel gating.
Physiological significance of ERK1/2-mediated regulation of sodium absorption. Garty and coworkers (33) speculated that hypotonic shock, TGF-␤, and calcium mobilization might be upstream signaling pathways that could utilize ERK2 phosphorylation of ENaC to regulate sodium absorption. The results of our studies with EGF and extracellular ATP demonstrate that at least two physiologically relevant receptor-signaling pathways in epithelia may regulate sodium transport via activation of ERK1/2. A wide range of physiological and pathophysiological conditions influences MAP kinase signaling in epithelial cells (41) . This is particularly relevant in polycystic kidney disease, in which abnormalities in the EGF/ EGFR axis have been implicated in disease progression (29) . Because of the extent to which MAP kinase activation contributes to inhibition of sodium transport by other receptor agonists and signaling pathways is undetermined and because the acute inhibition of sodium transport by EGF is readily reversible, phosphatase activity may represent another potential step for regulation.
